Royal Bank of Canada’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.19M | Sell |
185,258
-2,168
| -1% | -$48.2K | ﹤0.01% | 2542 |
|
|
2025
Q4 | $4.85M | Sell |
187,426
-183,257
| -49% | -$4.36M | ﹤0.01% | 2449 |
|
|
2025
Q3 | $9.55M | Buy |
370,683
+169,205
| +84% | +$4.16M | ﹤0.01% | 2188 |
|
|
2025
Q2 | $4.82M | Sell |
201,478
-16,719
| -8% | -$421K | ﹤0.01% | 2598 |
|
|
2025
Q1 | $5.42M | Sell |
218,197
-3,462
| -2% | -$82.9K | ﹤0.01% | 2196 |
|
|
2024
Q4 | $4.18M | Sell |
221,659
-12,673
| -5% | -$223K | ﹤0.01% | 2455 |
|
|
2024
Q3 | $3.53M | Buy |
234,332
+20,851
| +10% | +$356K | ﹤0.01% | 2558 |
|
|
2024
Q2 | $6.11M | Buy |
213,481
+188,089
| +741% | +$5.35M | ﹤0.01% | 2021 |
|
|
2024
Q1 | $742K | Sell |
25,392
-13,162
| -34% | -$404K | ﹤0.01% | 3691 |
|
|
2023
Q4 | $1.3M | Buy |
38,554
+7,559
| +24% | +$221K | ﹤0.01% | 3454 |
|
|
2023
Q3 | $951K | Buy |
30,995
+3,459
| +13% | +$125K | ﹤0.01% | 3486 |
|
|
2023
Q2 | $1.1M | Buy |
27,536
+15,013
| +120% | +$621K | ﹤0.01% | 3282 |
|
|
2023
Q1 | $510K | Sell |
12,523
-1,694
| -12% | -$67.4K | ﹤0.01% | 3850 |
|
|
2022
Q4 | $549K | Buy |
14,217
+6,781
| +91% | +$330K | ﹤0.01% | 4036 |
|
|
2022
Q3 | $396K | Sell |
7,436
-27,362
| -79% | -$1.52M | ﹤0.01% | 4226 |
|
|
2022
Q2 | $2.03M | Buy |
34,798
+50
| +0.1% | +$3.27K | ﹤0.01% | 2884 |
|
|
2022
Q1 | $2.65M | Buy |
34,748
+13,542
| +64% | +$903K | ﹤0.01% | 2794 |
|
|
2021
Q4 | $1.28M | Buy |
21,206
+3,436
| +19% | +$189K | ﹤0.01% | 3569 |
|
|
2021
Q3 | $996K | Buy |
17,770
+3,153
| +22% | +$182K | ﹤0.01% | 3698 |
|
|
2021
Q2 | $886K | Buy |
14,617
+4,255
| +41% | +$269K | ﹤0.01% | 3763 |
|
|
2021
Q1 | $727K | Sell |
10,362
-12,045
| -54% | -$860K | ﹤0.01% | 3868 |
|
|
2020
Q4 | $1.34M | Buy |
22,407
+15,320
| +216% | +$897K | ﹤0.01% | 3266 |
|
|
2020
Q3 | $426K | Sell |
7,087
-15,369
| -68% | -$893K | ﹤0.01% | 4000 |
|
|
2020
Q2 | $1.18M | Buy |
22,456
+524
| +2% | +$21.9K | ﹤0.01% | 3032 |
|
|
2020
Q1 | $736K | Buy |
21,932
+9,307
| +74% | +$387K | ﹤0.01% | 3283 |
|
|
2019
Q4 | $571K | Sell |
12,625
-1,857
| -13% | -$78.9K | ﹤0.01% | 3885 |
|
|
2019
Q3 | $551K | Sell |
14,482
-14,406
| -50% | -$575K | ﹤0.01% | 3782 |
|
|
2019
Q2 | $1.26M | Buy |
28,888
+11,682
| +68% | +$496K | ﹤0.01% | 3129 |
|
|
2019
Q1 | $655K | Sell |
17,206
-18,053
| -51% | -$705K | ﹤0.01% | 3545 |
|
|
2018
Q4 | $1.52M | Buy |
35,259
+18,216
| +107% | +$850K | ﹤0.01% | 2847 |
|
|
2018
Q3 | $837K | Sell |
17,043
-1,802
| -10% | -$77.9K | ﹤0.01% | 3507 |
|
|
2018
Q2 | $605K | Sell |
18,845
-7,627
| -29% | -$263K | ﹤0.01% | 3645 |
|
|
2018
Q1 | $825K | Buy |
26,472
+12,776
| +93% | +$455K | ﹤0.01% | 3311 |
|
|
2017
Q4 | $626K | Sell |
13,696
-394,399
| -97% | -$15.6M | ﹤0.01% | 3627 |
|
|
2017
Q3 | $15.3M | Buy |
408,095
+67,124
| +20% | +$2.7M | 0.01% | 1257 |
|
|
2017
Q2 | $16.3M | Buy |
340,971
+57,149
| +20% | +$2.65M | 0.01% | 1192 |
|
|
2017
Q1 | $12.9M | Sell |
283,822
-50,405
| -15% | -$2.18M | 0.01% | 1325 |
|
|
2016
Q4 | $10.8M | Sell |
334,227
-37,825
| -10% | -$1.26M | 0.01% | 1457 |
|
|
2016
Q3 | $12.7M | Buy |
372,052
+220,941
| +146% | +$8.66M | 0.01% | 1321 |
|
|
2016
Q2 | $5.1M | Buy |
151,111
+103,178
| +215% | +$5.07M | ﹤0.01% | 1886 |
|
|
2016
Q1 | $2.54M | Buy |
47,933
+45,898
| +2,255% | +$2.68M | ﹤0.01% | 2276 |
|
|
2015
Q4 | $156K | Sell |
2,035
-2,266
| -53% | -$128K | ﹤0.01% | 4687 |
|
|
2015
Q3 | $177K | Buy |
4,301
+2,661
| +162% | +$163K | ﹤0.01% | 4424 |
|
|
2015
Q2 | $116K | Buy |
1,640
+798
| +95% | +$62.8K | ﹤0.01% | 4732 |
|
|
2015
Q1 | $75K | Buy |
842
+228
| +37% | +$23.1K | ﹤0.01% | 4761 |
|
|
2014
Q4 | $54K | Sell |
614
-52
| -8% | -$4.92K | ﹤0.01% | 5022 |
|
|
2014
Q3 | $64K | Buy |
666
+316
| +90% | +$30.7K | ﹤0.01% | 4825 |
|
|
2014
Q2 | $32K | Sell |
350
-1,983
| -85% | -$151K | ﹤0.01% | 5042 |
|
|
2014
Q1 | $163K | Buy |
2,333
+2,033
| +678% | +$138K | ﹤0.01% | 4255 |
|
|
2013
Q4 | $17K | Buy |
300
+100
| +50% | +$5.26K | ﹤0.01% | 5317 |
|
|
2013
Q3 | $10K | Hold |
200
| – | – | ﹤0.01% | 5417 |
|
|
2013
Q2 | $6K | Buy |
+200
| New | +$5.79K | ﹤0.01% | 5414 |
|
Other funds holding PCRX
DPCM
VPM
VCM
